GNH USA

Europe — EMA

Novantrone (Mitoxantrone)

GNH USA supplies Novantrone (Mitoxantrone), an antineoplastic for acute myeloid leukemia, breast cancer and prostate cancer. Request a quote for supply.

Mitoxantrone

Request sourcing

1
Pack/s

What is Mitoxantrone?

Mitoxantrone, the active ingredient in Novantrone, is an anthracenedione presented as an injectable solution for intravenous use. It treats certain cancers and is also used off‑label for immunosuppression in multiple sclerosis.

GNH USA supplies Novantrone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Mitoxantrone used for?

Novantrone (mitoxantrone) is employed in oncology and hematology to target rapidly dividing cells.

Acute myeloid leukemia: helps achieve remission by targeting leukemic blasts. Metastatic breast cancer: reduces tumor burden and may improve survival. Prostate cancer: used in hormone‑refractory disease to control progression. Multiple sclerosis (off‑label): provides immunosuppression for severe, refractory cases.

What are the side effects of Mitoxantrone?

Common Side Effects: - Nausea and vomiting: gastrointestinal upset frequently reported during infusion. - Fatigue: persistent tiredness that may affect daily activities. - Alopecia: reversible hair loss occurring with treatment cycles. - Myelosuppression: reduced blood cell counts, increasing infection risk.

Serious or Rare Side Effects: - Cardiotoxicity: decreased left ventricular ejection fraction, requiring cardiac monitoring. - Secondary leukemia: rare development of a new hematologic malignancy. - Severe infection: opportunistic infections due to profound neutropenia. - Hepatic or pulmonary toxicity: abnormal liver enzymes or lung inflammation in rare cases.

What precautions apply to Mitoxantrone?

Precautions should be observed before and during therapy with Novantrone. - Cardiac monitoring: baseline and periodic echocardiograms to detect cardiotoxicity. - Hematologic assessment: regular CBCs to track myelosuppression. - Liver function tests: monitor hepatic enzymes for potential toxicity. - Pregnancy risk: drug is contraindicated in pregnancy (Category D). - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Mitoxantrone interact with?

Potential drug interactions must be reviewed prior to initiating Novantrone.

Major Interactions (Avoid): - Concurrent anthracyclines: additive cardiotoxic risk. - Live vaccines: increased risk of infection due to immunosuppression. - Strong CYP450 inhibitors: may alter drug clearance.

Moderate Interactions (Monitor Closely): - Anticoagulants: enhanced bleeding risk; monitor INR/PT. - Other myelosuppressive chemotherapies: cumulative bone‑marrow suppression. - Hormonal therapies: possible additive adverse effects on liver function.

Frequently asked questions

What conditions is Novantrone used to treat?+
Novantrone (mitoxantrone) is indicated for the treatment of acute myeloid leukemia, metastatic breast cancer, and hormone‑refractory prostate cancer. It is also employed off‑label as an immunosuppressive agent in severe, refractory multiple sclerosis.
How does mitoxantrone work in the body?+
Mitoxantrone intercalates into DNA and blocks topoisomerase II activity, preventing the resealing of DNA strands during replication. This results in double‑strand breaks and triggers apoptosis of rapidly dividing cells, such as cancerous and immune‑mediated cells.
What is the usual dose of Novantrone?+
The dosing regimen for Novantrone is individualized by the prescribing clinician based on the specific indication, patient weight, renal and hepatic function, and treatment protocol. Only a qualified healthcare professional should determine the appropriate dose.
Is Novantrone safe during pregnancy or breastfeeding?+
Novantrone is classified as Pregnancy Category D, indicating evidence of fetal risk. It is contraindicated in pregnant women and should not be used while breastfeeding because it can be excreted in milk and may harm the infant.
How do I order Novantrone from GNH USA?+
To request Novantrone, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does Novantrone compare with other chemotherapy agents?+
Novantrone belongs to the anthracenedione class and differs from anthracyclines such as doxorubicin by its distinct DNA intercalation profile and a lower incidence of certain cardiotoxic effects at equivalent doses. However, both share risks of myelosuppression and require careful cardiac monitoring.
What are the storage requirements for Novantrone?+
Novantrone must be stored refrigerated at 2‑8 °C. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the solution to maintain stability and potency.
How is Novantrone administered to patients?+
Novantrone is supplied as an injectable solution for intravenous infusion. It is administered by a qualified healthcare professional, typically over a prescribed period of time, using aseptic technique and appropriate infusion equipment.
What are the most serious risks associated with Novantrone?+
The most serious risks include cardiotoxicity (reduced heart function), secondary acute leukemia, severe infections due to profound neutropenia, and rare hepatic or pulmonary toxicity. Patients should be monitored closely for these events throughout therapy.
Who should not receive Novantrone?+
Novantrone is contraindicated in patients with known hypersensitivity to mitoxantrone or any component of the formulation, in pregnant women, and in individuals with pre‑existing severe cardiac dysfunction. Caution is also advised for patients with uncontrolled infections or significant hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Mitoxantrone
Route
Intravenous Use
Manufacturer
Mylan Ire Healthcare Limited
Origin
EU

Related products

Mitoxan

Mitoxan

Mitoxantrone

Medicamerc S.A
EU
Mitoxantron "ebewe"

Mitoxantron "ebewe"

Mitoxantrone

Ebewe Pharma
EU
Mitoxantron Accord

Mitoxantron Accord

Mitoxantrone

Accord Healthcare B.V.
EU
Mitoxantron Ebewe

Mitoxantron Ebewe

Mitoxantrone

Ebewe Pharma
EU